Shortening of Interoestrous interval (IEI) in dogs using low dose Cabergoline at early Anoestrus
Author(s):
Smitty J, Jayakumar C, Kurien MO and Metilda J
Abstract:
Dopamine agonists have been successful in inducing oestrus in dogs with primary and secondary anoestrus. The present study assessed the efficiency and safety of dopamine agonist, cabergoline at a low dose during early anoestrous stage in reducing the IEI in dogs. Seventeen healthy dogs that completed 90 ± 3 days following the previous proestrus were randomly allotted to treatment and control groups. Cabergoline @ 0.6µg/kg b.wt/day orally was given until onset of proestrus or until day 40, if no signs of proestrus were observed. All the treated dogs evinced proestrual bleeding within a mean period of 23.83 ± 4.21 days of start of treatment. A significant shortening of IEI (120.17±15.89 days) and a satisfactory conception rate (66.67%) was noticed in the induced dogs.
How to cite this article:
Smitty J, Jayakumar C, Kurien MO, Metilda J. Shortening of Interoestrous interval (IEI) in dogs using low dose Cabergoline at early Anoestrus. Pharma Innovation 2019;8(3):375-377.